Quarterly Sales Revenue: INR100.5 crore, 10.2% year-on-year growth. Total Income (Q3 FY26): INR1,005 million, 10.2% year-on-year growth. EBITDA (Q3 FY26): INR344 million, 0.4% year-on-year growth.
Revenue: INR1,778 crores for Q3 FY26. Gross Margin: Approximately 60% for Q3 FY26. EBITDA Margin: Over 27% for Q3 FY26. Generic Division Revenue: INR1,327 crores for Q3 FY26, 37% growth. CDMO Sales: ...
Total Gross Income: Increased 11.1% quarter on quarter to approximately INR13.4 billion. Total Net Income: Grew 9.3% sequentially to INR10.3 billion. Stand-alone Operating Margin: 43%. EBITDA Margin: ...
Granules India Ltd (BOM:532482) reported a strong Q3 FY26 with a 22% year-on-year revenue growth, reaching INR 13,879 million. EBITDA increased by 34% compared to the same period last year, indicating ...
Net Profit: INR 952 crore, a growth of 55% YoY and 45% QoQ. Adjusted Net Profit: INR 1,068 crore after accounting for gratuity provision impact. Annualized ROA: Improved to 0.9% from 0.6% in the ...
Range reports the president's appointment of Kevin Warsh as Fed Chair signals Fed independence and a market-first policy.
Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results